Post Content
Related Posts
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
A Santa Claus rally could come just in time next week to help stocks end the year on a high note
Investors will measure the response to this week’s selloff, which came at a time when markets are entering a strong seasonal period.
Here’s how much a ‘Made in the USA’ iPhone would cost
The White House says President Trump believes Apple can make a U.S. iPhone, but there are many reasons why analysts say that’s likely not possible.